The independent source for health policy research, polling, and news.
1 - 20 of 60 Results
Genesis HealthCare鈥檚 bankruptcy case in Dallas will allow the nursing home chain to avoid paying millions of dollars it promised for residents who were injured or died while in its care. Families say bankruptcy nullifies one of the main ways to hold nursing home owners accountable for poor care.
Studies increasingly find links between higher concentrations of certain pollutants and the prevalence of dementia.
As cognitive skills erode with age, driving skills weaken, but an aging driver may not recognize that. Advance directives on driving are one way to handle this challenge.
Deciding when, or whether, to buy long-term care insurance can be complex. Here鈥檚 what to know.
Quest Diagnostics is selling a blood test online to consumers. But results may not be reliable or easy to interpret. And it isn鈥檛 covered by insurance.
Clinics serving Alzheimer鈥檚 patients are working out the details of who will get treated with the new drug Leqembi. It won鈥檛 be for everyone with memory-loss symptoms.
The annual cost of lecanemab treatment quadruples if the expense of brain scans to monitor for bleeds and other associated care is factored in. The full financial toll likely puts it beyond reach for low-income seniors at risk of Alzheimer鈥檚, experts say.
Black patients and other minorities tend to be diagnosed at later stages of the disease, which would exclude them from use of Leqembi. Few Black people were included in the main trial of the drug.
Programs assisting people with dementia 鈥 and their caregivers 鈥 improve quality of life and care. But millions of unpaid family and friend caregivers may not know where or how to find help.
The proportion of Californians dying at home, rather than in a hospital or nursing home, accelerated during the pandemic, a trend that has outlasted the rigid lockdowns linked to the initial shift.
Health department officials anticipate having to transfer two dozen patients from the Montana State Hospital to another state-run facility if a bill to end involuntary commitments passes.
Leaders of the new Republican-led U.S. House kicked off their legislative agenda with two bills supported by anti-abortion groups. While neither is likely to become law, the move demonstrates how abortion will continue to be an issue in Washington. Meanwhile, as open enrollment for the Affordable Care Act nears its end in most states, the number of Americans covered by the plans hits a new high. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico, and Sarah Karlin-Smith of the Pink Sheet join KHN鈥檚 Julie Rovner to discuss these topics and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
The TikTok hashtag "dementia" has billions of views. Caregivers of people with Alzheimer's and other dementias have been using the site to swap tips and share the burdens of life with dementia.
The unprecedented early leak of a Supreme Court draft opinion that would overturn the landmark abortion-rights ruling Roe v. Wade has heated the national abortion debate to boiling. Meanwhile, the FDA, after years of consideration, moves to ban menthol flavors in cigarettes and cigars. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Shefali Luthra of the 19th, and Jessie Hellmann of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, Rovner interviews KHN鈥檚 Paula Andalo, who wrote the latest KHN-NPR 鈥淏ill of the Month鈥 episode about a family whose medical debt drove them to seek care south of the border.
Medicare has proposed limiting coverage of Aduhelm, the costly new drug to treat Alzheimer鈥檚 disease, and several prominent groups representing patients and their families are pressing the program to make it more widely available. But among individuals facing the disease, the outlook is more nuanced.
Nine seniors from across the country talk frankly about feeling alone and constrained, missing church, and family routines. They also share newfound hope and discoveries that arose from the crisis.
An epic battle is playing out behind the scenes over whether the government should pay for Aduhelm, an FDA-approved Alzheimer鈥檚 drug that scientists say has not been proven to work.
Medicare officials tentatively plan to restrict the use of a controversial Alzheimer鈥檚 drug to only those patients participating in clinical trials, while the Department of Health and Human Services looks into lowering the monthly Medicare Part B premium. Meanwhile, covid confusion still reigns, as the Biden administration moves, belatedly, to make more masks and tests available. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN鈥檚 Julie Rovner to discuss these issues and more.
Sen. Joe Manchin (D-W.Va.) dealt a blow to congressional efforts to pass President Joe Biden鈥檚 domestic agenda bill, forcing Democrats to regroup starting in 2022. Meanwhile, the omicron covid variant spreads rapidly in the U.S., threatening the stability of the nation鈥檚 health care system. Joanne Kenen of Politico and the Johns Hopkins School of Public Health, Rachel Cohrs of Stat and Sarah Karlin-Smith of the Pink Sheet join KHN鈥檚 Julie Rovner to discuss these issues and more, plus a look back at the year in health policy. Also this week, Rovner interviews Ceci Connolly, president and CEO of the Alliance of Community Health Plans.
The condition can be an early signal of Alzheimer鈥檚 disease, but not always. Other health concerns could be causing thinking or memory problems, and the new drug, Aduhelm, would not be appropriate for those patients.
漏 2026 麻豆女优